Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-23 5:00 pm Sale |
2020-09-21 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,864,721 9.400% |
-137,500 (-6.87%) |
Filing History |
| 2020-09-18 5:12 pm Purchase |
2020-09-15 | 13D | RESTORBIO INC TORC |
ORBIMED ADVISORS LLC | 5,513,015 28.100% |
682,628 (+14.13%) |
Filing History |
| 2020-08-19 5:14 pm Purchase |
2020-08-06 | 13G | Arvinas, Inc. ARVN |
ORBIMED ADVISORS LLC | 1,177,483 4.100% |
1,177,483 (New Position) |
Filing History |
| 2020-08-18 4:31 pm Purchase |
2020-08-10 | 13D | Acutus Medical, Inc. AFIB |
ORBIMED ADVISORS LLC | 5,810,525 20.900% |
5,810,525 (New Position) |
Filing History |
| 2020-07-30 6:26 pm Unchanged |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 3,816,206 16.000% |
0 (Unchanged) |
Filing History |
| 2020-07-27 5:57 pm Purchase |
2020-07-17 | 13G | PANDION THERAPEUTICS INC PAND |
ORBIMED ADVISORS LLC | 1,040,825 3.600% |
1,040,825 (New Position) |
Filing History |
| 2020-07-16 5:12 pm Sale |
2020-07-14 | 13D | Alector, Inc. ALEC |
ORBIMED ADVISORS LLC | 2,725,313 3.500% |
-2,776,735 (-50.47%) |
Filing History |
| 2020-07-13 4:20 pm Unchanged |
2020-07-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 2,002,221 11.900% |
0 (Unchanged) |
Filing History |
| 2020-07-10 11:55 am Sale |
2020-07-07 | 13D | Alector, Inc. ALEC |
ORBIMED ADVISORS LLC | 5,502,048 7.000% |
-964,944 (-14.92%) |
Filing History |
| 2020-07-06 5:57 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,997,981 7.200% |
2,997,981 (New Position) |
Filing History |
| 2020-07-01 5:31 pm Unchanged |
2020-06-30 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 21.200% |
0 (Unchanged) |
Filing History |
| 2020-06-29 6:27 pm Purchase |
2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 12,714,404 24.400% |
12,714,404 (New Position) |
Filing |
| 2020-06-25 8:19 pm Purchase |
2020-06-19 | 13D | Repare Therapeutics Inc. RPTX |
ORBIMED ADVISORS LLC | 3,276,325 8.900% |
3,276,325 (New Position) |
Filing History |